Coronary Artery Disease
Conditions
Interventions
None listed
Sponsors
Department of Cardiovascular Medicine, Kyoto Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: We searched all reported trials comparing Absorb bioabsorbable vascular scaffold (BVS) and everolimus-eluting stent (EES), and single-arm study evaluated the Absorb BVS or EES, with beyond 1 year results after coronary stent implantation. We identified relevant studies by searching PubMed, the Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, conference proceedings, and presentations from major cardiovascular meetings using the keywords "biosbsorbable", "bioresorbable", "scaffold", "everolimus", and "stent", without language restrictions. We also manually checked reference lists of the identified reports and relevant reviews. From the gathered studies, randomized controlled trials (RCT) and observational study comparing the effect of Absorb BVS and EES on ST or TLF were extracted. Furthermore, studies evaluated Absorb BVS or everolimus-eluting stent as a single-arm design with the results of ST or TLF with enough 2-year follow up were also extracted to calculate the estimated event rate of the outcome measure between 1 and 2 year from device implantation.
Exclusion criteria
Exclusion criteria: Studies without enough 2-year follow-up were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stent/scaffold Thrombosis | — |
Secondary
| Measure | Time frame |
|---|---|
| Target Lesion Failure | — |
Countries
Japan
Contacts
Public ContactToshiaki Toyota
Kyoto Graduate School of Medicine Department of Cardiovascular Medicine
Outcome results
None listed